secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2023-12-07T23:59:59+00:00
Accession:  0001493152-23-044012
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem restructures convertible notes; changes governing law, reissues under Section 3(a)(9)
--------------------------------------------------------------------------------

- Modified eight series of senior convertible notes issued Dec 2022–Sep 2023; no new consideration paid.
- Changed governing law from New York to Delaware; notes reissued under Securities Act Section 3(a)(9) exemption.
- Conversion price set at $0.0635 per share; default interest rate 12%; beneficial ownership cap 4.99%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223044012/0001493152-23-044012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223044012/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-044012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer